Dr. Mohamed Shehata

Dr. Mohamed Shehata

Verified
Consultant
  • Interventional Cardiologist
MBBS, MS, MD
Experience
18 yrs
AboutEducationSimilar doctorsFAQ

About Dr. Mohamed Shehata

Dr. Mohamed Shehata is a distinguished Interventional Cardiologist with over 18 years of experience, committed to delivering top-tier cardiac care. With a comprehensive background in complex cardiac procedures, he has established a reputation for precision and excellence in the field of cardiology.

Why Choose Dr. Shehata?

  • Extensive Interventional Expertise: With over 18+ years of experience and a vast number of successful cases, Dr. Shehata has a proven track record of treating various coronary conditions and performing emergency cardiac procedures.
  • Advanced Techniques & Specialised Expertise: He is known for diagnostic and interventional techniques, including Coronary Imaging (IVUS-OCT) and Coronary Physiological Assessment (FFR). His expertise extends to Emergency Cardiac Procedures such as pericardial tapping and temporary pacing, as well as both emergency (primary) and elective coronary interventions.
  • Leader in Interventional Cardiology: Dr. Shehata is a respected interventional cardiologist with extensive expertise from prestigious medical facilities.
  • Board Certifications and Fellowships: Dr. Shehata holds significant credentials, including an MD in Cardiology and fellowships from the European Society of Cardiology (FESC) and the Society for Cardiac Angiography & Interventions (FSCAI), underscoring his advanced training and expertise.

Location

  • VerifiedMBBS, Ain Shams University, Cairo, Egypt(2003)
  • VerifiedMS, Ain Shams University, Cairo, Egypt(2007)
  • VerifiedMD, Ain Shams University, Cairo, Egypt(2011)
  • VerifiedFellowship, Fellowship

Papers Published

  • Shehata M. Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention. Am J Cardiol. 2014 Aug 1;114(3):389-94. doi: 10.1016/j.amjcard.2014.04.052. Epub 2014 May 16.
+ Read More
  • Shehata M, Hamza M. Impact of High Loading Dose of Atorvastatin in Diabetic Patients with Renal Dysfunction Undergoing Elective Percutaneous Coronary Intervention: A Randomized Controlled Trial. Cardiovasc Ther. 2015 Feb 9. doi: 10.1111/1755-5922.12108.
  • Shehata M. Value of Two-Dimensional Strain Imaging in Prediction of Myocardial Function Recovery after Percutaneous Revascularization of Infarct-Related Artery. Echocardiography. 2014 Nov 24. doi: 10.1111/echo.12704.
  • Shehata M. Relation between ischemic threshold measured during dobutamine stress echocardiography and coronary angiographic features. Kardiol Pol. 2014 May 20. doi: 10.5603/KP.a2014.0111.
  • Mohamed Shehata. Late Re-assessment of Myocardial Viability After Acute Myocardial Infarction: Is There Still a Chance?per Title. Experimental & Clinical Cardiology. Volume 20, Issue 1, 2014. (http://www.cardiologyacademicpress.com/?p=19736/Mohamed Shehata/Exp Clin Cardiol Vol 20 Issue1 pages 1062-1092/ 2014).
  • Shehata M. Atropine first is safer than conventional atropine administration in older people undergoing dobutamine stress echocardiography. Ther Adv Cardiovasc Dis. 2014 Oct;8(5):176-84. doi: 10.1177/1753944714538112. Epub 2014 Jun 5.
  • Shehata M. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention. J Interv Cardiol. 2014 Oct;27(5):472-81. doi: 10.1111/joic.12142. Epub 2014 Aug 30.
  • Shehata M, Samir A, Dardiri M. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients. J Interv Cardiol. 2017 Aug 15. doi: 10.1111/joic.12427.
  • Hashad IM, Hossni NM, Abdel Rahman MF, Shehata M, Shaban G, Gad MZ. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction. Curr Pharm Biotechnol. 2018;19(4):336-342. doi: 10.2174/1389201019666180605125803.
  • Khalil A, Shehata M, Abdeltawab A, Onsy A. Red blood cell distribution width and coronary artery disease severity in diabetic patients. Future Cardiol. 2019 Sep;15(5):355-366. doi: 10.2217/fca-2018-0066.

Send Your Enquiry

Fill in your details and our medical experts will contact you within 24 hours.

By submitting I agree to the Terms of Use and Privacy Policy of Vaidam Health.

Want to consult the doctor?

Don't Ignore Your Health!

Other Top Interventional Cardiologist In Dubai

Dr. Ali Kazem Moussavi

Dr. Ali Kazem Moussavi

Non-Invasive Cardiologist
King's College Hospital, Dubai · Dubai
11+ years of experience
Chat IconChat
Dr Adnan Alkhalefeh

Dr Adnan Alkhalefeh

Interventional Cardiologist
NMC Royal Hospital, DIP, Dubai · Dubai
14+ years of experience
Chat IconChat
Dr. Rafik Abu Samra

Dr. Rafik Abu Samra

4.7 (174 Ratings)
Interventional Cardiologist
CMC Dubai · Dubai
21+ years of experience · 6,000+ surgeries
Chat IconChat

FAQ's About Dr. Mohamed Shehata

Where does Dr. Mohamed Shehata practice?

Dr. Mohamed Shehata practices at Zulekha Hospital, Dubai

What is the specialty of Dr. Mohamed Shehata?

Dr. Mohamed Shehata specialty is Interventional Cardiologist

What is the experience of Dr. Mohamed Shehata?

Dr. Mohamed Shehata is Interventional Cardiologist with 18 years of experience.

Our Network

500+

Top Hospitals

10,000+

Doctors

50+

Cities

10+

Countries

Need Assistance?Chat